Asymptomatic COVID-19 Testing - Clinical Validation Req. & The Change in FDA Regulatory Authority over LDTs

We will begin the discussion of the FDA's new Emergency Use Authorization (EUA) requirements for testing asymptomatic patients and walk through the more robust clinical validation that is required in order to maintain compliance. We will also discuss clinical validation requirements, the change in FDA regulatory authority over LDTs, and other frequently asked questions.